Fund shareholders of Terns Pharmaceuticals Inc
ISIN US8808811074 · United States · LEI 254900S1ZDQMF4MYP709
- Fund shareholders
- 2
- Of which ETFs
- 0 2 other funds
- Value held
- ≈ 1.2M $ 11.1M SEK
- Share of capital
- 0.0 % of 115.4M shares on Mar 27, 2026
A single tracked fund declares this company. So these figures do not say who owns it.
2 funds hold this company. This table lists the 1 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. The “Fund reports” tab lists it, with its weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Lannebo Hälsa och Ny Teknik Lannebo Kapitalförvaltning AB | 22,152 | 11.1M SEK | 3.08 % | 0.02 % | as of Mar 31, 2026 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 0.33 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Lannebo Hälsa och Ny Teknik Lannebo Kapitalförvaltning AB | 3.08 % | as of Mar 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 0.33 % | as of Sep 30, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 222 | +12 | 23,437,035 | -6.0 % |
| 2026Q1 | 210 | +70 | 24,921,116 | +74.7 % |
| 2025Q4 | 140 | +11 | 14,268,936 | +6.8 % |
| 2025Q3 | 129 | -15 | 13,359,325 | +0.8 % |
| 2025Q2 | 144 | 0 | 13,252,582 | -12.6 % |
| 2025Q1 | 144 | +4 | 15,162,431 | +22.4 % |
| 2024Q4 | 140 | +16 | 12,386,883 | +41.6 % |
| 2024Q3 | 124 | +6 | 8,748,804 | -11.1 % |
| 2024Q2 | 118 | +2 | 9,844,476 | +1.6 % |
| 2024Q1 | 116 | -4 | 9,685,599 | -3.9 % |
| 2023Q4 | 120 | 10,075,219 |
Institutional managers
307 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 9,569,585 | 504.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 6,449,140 | 340M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 5,695,000 | 300.2M $ | as of Mar 31, 2026 |
| Holocene Advisors, LP | 4,115,828 | 217M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 3,218,810 | 169.7M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,011,558 | 158.8M $ | as of Mar 31, 2026 |
| HBK INVESTMENTS L P | 2,950,000 | 155.5M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 2,869,728 | 151.8M $ | as of Mar 31, 2026 |
| LORD, ABBETT & CO. LLC | 2,812,938 | 148.3K $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 2,779,445 | 146.5M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,409,019 | 127M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,316,544 | 122.2M $ | as of Mar 31, 2026 |
| GLAZER CAPITAL, LLC | 2,295,498 | 121K $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 2,216,499 | 116.9M $ | as of Mar 31, 2026 |
| Nearwater Capital Markets, Ltd | 2,150,400 | 113.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,139,662 | 112.8M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,124,817 | 112M $ | as of Mar 31, 2026 |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 1,975,800 | 104.2M $ | as of Mar 31, 2026 |
| ACORN CAPITAL ADVISORS, LLC | 1,746,264 | 92.1M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 1,655,575 | 87.3M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 1,500,000 | 79.1M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 1,470,057 | 77.5M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 1,456,378 | 76.8M $ | as of Mar 31, 2026 |
| Capital International Investors | 1,424,504 | 75.1M $ | as of Mar 31, 2026 |
| Vivo Capital, LLC | 1,334,418 | 70.4M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Terns Pharmaceuticals Inc". https://titelia.com/en/stocks/terns-pharmaceuticals-inc-US8808811074